Retrospective analysis of efficacy and safety of third-line chemotherapy for metastatic colorectal cancer among elderly patients receiving targeted therapy in early lines
Conclusion Third-line chemotherapy treatment of elderly MCRC patients was associated with a minor clinical response, a considerable number of side effects, but a longer survival rate. Third-line chemotherapy in fit elderly patients should be pursued, however, protocols must be adjusted before third-line treatment is implemented.
Source: Journal of Clinical Gerontology and Geriatrics - Category: Geriatrics Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Geriatrics | Study | Thrombocytopenia | Toxicology